These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16039822)

  • 1. [Residual neuromuscular blockade].
    Beaussier M; Boughaba MA
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1266-74. PubMed ID: 16039822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and complications of post operative residual paralysis].
    Baillard C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S41-5. PubMed ID: 19887276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine.
    Miller RD; Ward TA
    Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of current management of neuromuscular block in the United States and Europe.
    Naguib M; Kopman AF; Lien CA; Hunter JM; Lopez A; Brull SJ
    Anesth Analg; 2010 Jul; 111(1):110-9. PubMed ID: 19910616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis.
    Naguib M; Kopman AF; Ensor JE
    Br J Anaesth; 2007 Mar; 98(3):302-16. PubMed ID: 17307778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival.
    Bronsert MR; Henderson WG; Monk TG; Richman JS; Nguyen JD; Sum-Ping JT; Mangione MP; Higley B; Hammermeister KE
    Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Residual neuromuscular blockade].
    Fuchs-Buder T; Schmartz D
    Anaesthesist; 2017 Jun; 66(6):465-476. PubMed ID: 28573344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetected residual neuromuscular block has consequences.
    Kopman AF
    Anesthesiology; 2008 Sep; 109(3):363-4. PubMed ID: 18719434
    [No Abstract]   [Full Text] [Related]  

  • 12. Perioperative train-of-four monitoring and residual curarization.
    Shorten GD; Merk H; Sieber T
    Can J Anaesth; 1995 Aug; 42(8):711-5. PubMed ID: 7586111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular monitoring: old issues, new controversies.
    Kopman AF
    J Crit Care; 2009 Mar; 24(1):11-20. PubMed ID: 19272534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis.
    Carvalho H; Verdonck M; Cools W; Geerts L; Forget P; Poelaert J
    Br J Anaesth; 2020 Oct; 125(4):466-482. PubMed ID: 32680607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block.
    Murphy GS; Brull SJ
    Anesth Analg; 2010 Jul; 111(1):120-8. PubMed ID: 20442260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.